首页> 外文期刊>Journal of Translational Medicine >Integrated analysis of miRNA, gene, and pathway regulatory networks in hepatic cancer stem cells
【24h】

Integrated analysis of miRNA, gene, and pathway regulatory networks in hepatic cancer stem cells

机译:肝癌干细胞中miRNA,基因和途径调控网络的综合分析

获取原文
获取外文期刊封面目录资料

摘要

Background Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide. HCC has a poor prognosis associated with tumor recurrence and drug resistance, which has been attributed to the existence of hepatic cancer stem cells (HCSCs). However, the characteristics and regulatory mechanisms of HCSCs remain unclear. We therefore established a novel system to enrich HCSCs and we demonstrate that these HCSCs exhibit cancer stem cell properties. Methods We used miRNA and mRNA high-throughput sequencing data sets to determine molecular signatures and regulatory mechanisms in HCSCs. Paired miRNA and gene deep sequencing data in HCSCs versus HCC cells were used to identify candidate biomarkers of HCSCs. Using network analysis, we studied the relationship between miRNA and gene biomarkers, and KEGG pathway enrichment analysis was performed to study the function of candidate biomarkers. Results We identified 9 up- and 9 down-regulated miRNAs and 115 up- and 402 down-regulated genes in HCSCs compared with HCC cells. A miRNA-gene network was constructed using 651 miRNA–gene interactions (between 7 up-regulated miRNAs and 274 down-regulated genes), and 103 miRNA–gene interactions (between 9 down-regulated miRNAs and 62 up-regulated genes). Pathway enrichment analysis identified five tumor invasion- and metastasis-related pathways and MAPK signaling associated with HCSCs. We further discovered two novel pathways that likely play a role in the regulation of HCSCs. Conclusions We identified a molecular expression signature and pathway regulatory mechanisms in HCSCs with potential diagnostic and therapeutic value.
机译:背景技术肝细胞癌(HCC)是全球最常见的恶性肿瘤之一。 HCC与肿瘤复发和耐药性相关的预后较差,这归因于肝癌干细胞(HCSC)的存在。但是,HCSC的特征和监管机制仍不清楚。因此,我们建立了富集HCSC的新系统,并且我们证明了这些HCSC表现出癌症干细胞特性。方法我们使用miRNA和mRNA高通量测序数据集来确定HCSC中的分子标记和调控机制。 HCSC与HCC细胞中的成对miRNA和基因深度测序数据用于鉴定HCSC的候选生物标记。使用网络分析,我们研究了miRNA与基因生物标志物之间的关系,并进行了KEGG通路富集分析以研究候选生物标志物的功能。结果与HCC细胞相比,我们在HCSC中鉴定出9个上调和9个下调的miRNA,以及115个上调和402个下调的基因。使用651个miRNA基因相互作用(在7个上调的miRNA和274个下调基因之间)和103个miRNA基因相互作用(在9个下调的miRNA和62个上调基因之间)构建了miRNA基因网络。途径富集分析确定了与HCSC相关的五种肿瘤侵袭和转移相关途径以及MAPK信号传导。我们进一步发现了两条可能在HCSC调节中起作用的新途径。结论我们确定了具有潜在诊断和治疗价值的HCSC中的分子表达特征和途径调控机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号